Bony increased-offset reverse shoulder arthroplasty vs. metal augments in reverse shoulder arthroplasty: a prospective, randomized clinical trial with 2-year follow-up

J Shoulder Elbow Surg. 2022 Mar;31(3):591-600. doi: 10.1016/j.jse.2021.11.007. Epub 2021 Dec 27.

Abstract

Background: Reverse shoulder arthroplasty (RSA) is rapidly being adopted as the standard procedure for a growing number of shoulder pathologies. Lateralization of the glenoid component is known to reduce the incidence of scapular notching and possibly improve postoperative range of motion. A number of methods are used for glenoid component lateralization, including bony increased-offset reverse shoulder arthroplasty (BIO-RSA) and porous metal-augmented baseplates. Presently, there exists little comparative literature on bone vs. metal lateralization. Therefore, the purpose of this study was to compare BIO-RSA to metal-augmented glenoid baseplates by assessing clinical outcomes and baseplate migration using model-based radiostereometric analysis.

Methods: A power analysis indicated 40 patients would be required for this radiostereometric study. Therefore, 41 shoulders were prospectively randomized to receive either glenoid bone grafting (BIO-RSA) or a porous metal-augmented wedge-shaped titanium baseplate for primary reverse shoulder arthroplasty. At the time of primary surgery, all patients also underwent implantation of 8 tantalum marker beads in the glenoid and coracoid. Following surgery, participants were imaged using a calibrated, stereo radiographic technique. Radiographs were acquired at 6 weeks (baseline), 3 months, 6 months, 1 year, and 2 years postoperatively. Migration of the prosthesis was compared between bone and metal lateralization groups at each time point using a mixed effects model with Bonferroni test for multiple comparisons. Outcome measures were acquired preoperatively and 2 years postoperatively.

Results: No significant differences were observed along any translation or rotation axis at any time point for either glenoid fixation group (P ≥ .175). Mean total glenoid component translation (± standard deviation) 2 years postoperatively was 0.4 ± 0.2 mm and 0.5 ± 0.3 mm for BIO-RSA and metal-augmented baseplates, respectively (P = .784). No significant differences were observed between groups in active range of motion; pain; American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form score; Simple Shoulder Test score; Disabilities of the Arm, Shoulder, and Hand score; Constant Shoulder score; or Subjective Shoulder Value (P ≥ .117), with the exception of increased active external rotation in the BIO-RSA cohort (P = .036).

Conclusion: This randomized clinical trial assessed reverse shoulder arthroplasty glenoid component migration using model-based radiostereometric analysis. At 2-year follow-up, our results indicate both BIO-RSA and porous metal wedge augmented baseplates provide stable initial fixation, which is maintained at 2 years' follow-up, with no substantial differences in clinical outcomes.

Keywords: BIO-RSA; Reverse shoulder arthroplasty; augmented implant; implant migration; patient-reported outcome measures; radiostereometric analysis.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Arthroplasty, Replacement, Shoulder* / methods
  • Follow-Up Studies
  • Humans
  • Prospective Studies
  • Range of Motion, Articular
  • Retrospective Studies
  • Shoulder Joint* / diagnostic imaging
  • Shoulder Joint* / surgery
  • Shoulder Prosthesis*
  • Treatment Outcome